Ambrx Biopharma Cayman, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
La Jolla, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Ambrx Biopharma Cayman, Inc. has filed 164 SEC EDGAR filings since 03 Feb 2021

SEC filing history

Showing 51-75 of 164 matching filings.

Per page
25
Current page
3
CORRESP

CORRESP filing

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40505

ARS

Filing date
28 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40505

DEF 14A

Filing date
28 Apr 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92634

SC 13G/A filing

Filing date
27 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Apr 2023
Reporting date
18 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40505

PRE 14A

Filing date
18 Apr 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2023
Reporting date
13 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEL AM File 333-271008

DEL AM

Filing date
03 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-271008

S-3

Filing date
30 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-271005

S-8

Filing date
30 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Mar 2023
Reporting date
14 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-40505

CERT filing

Filing date
16 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25 File 001-40505

25

Filing date
16 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92634

SC 13G

Filing date
16 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B/A File 001-40505

8-A12B/A

Filing date
16 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
13 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92634

AMENDMENT NO. 3

Filing date
13 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Mar 2023
Reporting date
27 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Mar 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92634

AMBRX BIOPHARMA INC.

Filing date
08 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .